Literature DB >> 12877702

Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator.

Christian Wolpert1, Werner Jung, Susanne Spehl, Rainer Schimpf, Heyder Omran, Burghard Schumacher, Bahman Esmailzadeh, Dirk Tenzer, Rahul Mehra, Berndt Lüderitz.   

Abstract

Atrial tachyarrhythmias play an important role in the treatment of patients with malignant ventricular tachyarrhythmias not only with respect to inappropriate discharges but also to left ventricular function and stroke risk. A combined dual chamber defibrillator provides separate therapies for atrial and ventricular tachyarrhythmias. To assess the incidence of atrial tachyarrhythmias in patients with this dual chamber implantable defibrillator, 40 patients with ventricular tachyarrhythmias and concomitant atrial tachyarrhythmias and/or AV conduction disturbances were included in a prospective study. During a mean follow-up of 25 +/- 11 months, 26 of 40 patients had a total of 1,430 recurrences of atrial tachyarrhythmias. The vast majority of the atrial tachyarrhythmias with regular atrial cycles had a mean median atrial cycle length of 235 +/- 37 ms and a mean duration of 34 +/- 144 minutes. Atrial tachyarrhythmias with irregular atrial cycles exhibited a median atrial cycle length of 198 +/- 31 ms and had a mean duration of 246 +/- 1,264 minutes. In addition, 67% of 375 tachyarrhythmias, in which the median ventricular cycle length during the ongoing episode could be documented, had a ventricular rate <100 beats/min. Continuous atrial arrhythmia detection with a dual chamber ICD reveals a high incidence of atrial tachyarrhythmias with a predominantly short duration of paroxysmal recurrences <1 hour in the vast majority of episodes.

Entities:  

Mesh:

Year:  2003        PMID: 12877702     DOI: 10.1046/j.1460-9592.2003.t01-1-00254.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.

Authors:  Jakob Schroder; Olivier Bouaziz; Bue Ross Agner; Torben Martinussen; Per Lav Madsen; Dana Li; Ulrik Dixen
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

Review 2.  ICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literature.

Authors:  Rhanderson N Cardoso; Chris Healy; Juan Viles-Gonzalez; James O Coffey
Journal:  Indian Pacing Electrophysiol J       Date:  2016-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.